article thumbnail

Omnicell Unveils Specialty Pharmacy Services in Summer 2022 Release

Omnicell

Carmine DeNardo VP and General Manager, Specialty Pharmacy Services, Omnicell Despite the widespread adoption of electronic health records, pharmacy management systems, and other digital technologies, managing patients and medications across the continuum of care remains a significant challenge.

article thumbnail

Addressing Specialty Pharmacy Adherence Challenges Head On

Omnicell

Sarah Kester, PharmD Pharmaceutical Program Manager, Omnicell Specialty Pharmacy Services Medication non-adherence is a crippling problem in healthcare today, causing unnecessary hospitalizations and escalating costs. 2 Specialty pharmacy is a hotbed for adherence issues.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ASHP Midyear 2022: Partnering for Optimized Pharmacy Outcomes

Omnicell

As healthcare navigates new and growing challenges post COVID-19 – including labor challenges, supply chain challenges, and disconnected systems – pharmacy leaders need innovative solutions that deliver optimized business and clinical outcomes for medication management. And Omnicell is more than a vendor.

article thumbnail

Omnicell Announces Acquisition of 340B Link Business

Omnicell

Ngo EVP, Marketing, Strategy & Business Development, Omnicell For more than 25 years, the 340B Drug Pricing Program has provided financial assistance to hospitals and other healthcare facilities serving vulnerable communities to manage rising prescription drug costs.

article thumbnail

Federal 340B Ruling Underscores Need for Balanced Pharmacy Program

Omnicell

Court of Appeals for the Third Circuit decided that three drug companies – AstraZeneca, Novo Nordisk, and Sanofi – did not violate federal law when they imposed restrictions, conditions, and other limitations on 340B discount pricing on drugs dispensed at community and specialty pharmacies.

article thumbnail

NASP 2022 Reveals a Pharmacy Landscape Shifting to Specialty

Omnicell

Kristen Dowd Director, Pharmacy Management Services, Omnicell If the 2022 NASP (National Association of Specialty Pharmacy) Annual Meeting and Expo is any indication, we are approaching a time when specialty pharmacy simply becomes pharmacy – when complex, high-touch biologics become nearly as ubiquitous as their broad-spectrum counterparts.

article thumbnail

In the Face of Resistance, 340B Coalition Summer Conference Proves Program’s Worth

Omnicell

During an Omnicell-hosted View from Capitol Hill Luncheon and Panel Discussion , Cathy White, 340B Pharmacy Financial Analyst at Cone Health, explained how manufacturer restrictions have impacted her organization. Omnicell can be a valued partner in this effort.